Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial
Titel:
Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial
Auteur:
Rao, Sheela Samalin-Scalzi, Emmanuelle Evesque, Ludovic Ben Abdelghani, Meher Morano, Federica Roy, Amitesh Dahan, Laetitia Tamberi, Stefano Dhadda, Amandeep Singh Saunders, Mark P Casanova, Nathalie Guimbaud, Rosine Lievre, Astrid Maurel, Joan Fakih, Marwan Tian, Chuan Harrison, Jill Jones, Mark M Cornfeld, Mark Spano, Jean-Philippe Rochefort, Pauline
Verschenen in:
Lancet
Paginering:
Jaargang 405 () nr. 10495 pagina's 2144-2152
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license